50 percent of patients hospitalized with COVID-19 and 19 percent of asymptomatic patients had at least one post-COVID-19 condition

Wide variation seen in continuity of nursing staff for home health care visits to dementia patients following hospitalization

However, opioids still commonly dispensed, with high-risk prescribing practices suspected in young children

Increased in-hospital mortality for COVID-19 patients with schizophrenia versus those without severe mental illness

Donanemab has already received a 'breakthrough therapy' designation from the FDA

Odds ratios for adverse mental health symptoms, especially suicidal ideation, highest for those in both roles

Incidence of dementia increased at age 66 and 80 years for those with schizophrenia versus those without serious mental illness